title: Fluoroquinolone-resistant tuberculosis at a medical centre in Taiwan, 2005-10.
authors.forename: Chih-Cheng
authors.initials: CC
authors.lastname: Lai
authors.forename: Che-Kim
authors.initials: CK
authors.lastname: Tan
authors.forename: Yu-Tsung
authors.initials: YT
authors.lastname: Huang
authors.forename: Chun-Hsing
authors.initials: CH
authors.lastname: Liao
authors.forename: Po-Ren
authors.initials: PR
authors.lastname: Hsueh
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D010131:Aminosalicylic Acid / Q000494:pharmacology; D000995:Antitubercular Agents / Q000494:pharmacology*; D024881:Drug Resistance, Bacterial; D004977:Ethambutol / Q000494:pharmacology; D005000:Ethionamide / Q000494:pharmacology; D005260:Female; D024841:Fluoroquinolones / Q000494:pharmacology*; D006801:Humans; D007538:Isoniazid / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D015242:Ofloxacin / Q000494:pharmacology; D017828:Rifabutin / Q000494:pharmacology; D012293:Rifampin / Q000494:pharmacology; D013307:Streptomycin / Q000494:pharmacology; D013624:Taiwan / Q000453:epidemiology; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology
chemical_list: D000995:Antitubercular Agents; D024841:Fluoroquinolones; D017828:Rifabutin; D010131:Aminosalicylic Acid; D004977:Ethambutol; D015242:Ofloxacin; D005000:Ethionamide; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin